3Slonim AE, Bulone L, Ritz S, et al. Identification of two subtypes of infantile acid maltase deficiency. J Pediatr, 2000, 137: 283-285.
4van der Pioeg AT, Reuser AJ. Pompe's disease. Lancet, 2008, 372: 1342-1353.
5Pettersen MD, Du W, Skeens ME, et al. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr, 2008, 21: 922-934.
6Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and theChamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Eehocardiogr, 2005, 15: 1440-1463.
7Martiniuk F, Mehler M, Pellicer A, et al. Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients. Proc Natl Acad Sci U S A, 1986, 83:9641-9644.
8Ausems MG, Verbiest J, Hermans MP, et al. Frequency of glycogen storage disease type lI in the Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet, 1999, 7 : 713-716.
9Gillette PC, Nihill MR, Singer DB. Electrophysiological mechanism of the short PR interval in Pompe disease. Am J Dis Child, 1974, 128: 622-626.
10Kishnani P, Hwu W, Mandel H, et al. A retrospective, muhinational, muhicenter study on the natural history of infantile- onset Pompe disease. J Pediatr, 2006, 148 : 671-6"76.
